Clinical trial
Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4
NCT00277862 · Ain Shams University, Other · Completed
Key facts
| NCT number | NCT00277862 |
|---|---|
| Title | Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4 |
| Official title | Role of Rapid Virologic Response in Determining Treatment Duration of Peginterferon Alfa-2b/Ribavirin in Chronic Hepatitis C Genotype 4 |
| Lead sponsor | Ain Shams University, Other |
| Collaborators | Schering-Plough Industry Fulbright Tempus AI International Society for Infectious Diseases |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | Pegylated IFN- alpha 2b, Ribavirin |
| Enrollment | 280 |
| Start date | Apr 1, 2002 |
| Primary completion | Mar 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Jan 18, 2006 |
| Last update posted | Feb 26, 2008 |
| Countries | Egypt |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: